c-Myc 詳細
Molecule Name
Myc proto-oncogene protein
分子の別称
c-Myc,MYC,MRTL,bHLHe39
Drug Development Progress
治験薬の数10
市販薬剤の数0
研究＆開発段階Phase 2 Clinical
ターゲットの別称
Class E Basic Helix-Loop-Helix Protein 39，Transcription Factor P64，Proto-Oncogene C-Myc，Myc-Related Translation/Localization Regulatory Factor，Avian Myelocytomatosis Viral Oncogene Homolog，V-Myc Myelocytomatosis Viral Oncogene Homolog，Myc Proto-Oncogene Protein，BHLHE39，C-Myc，MRTL，MYCC，Proto-Oncogene Proteins c-myc，MYC，MYC Proto-Oncogene， BHLH Transcription Factor，V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
バックグランド
The c-Myc tag is a widely used epitope tag in molecular biology for protein expression and detection. Derived from the human c-Myc oncoprotein. This tag is typically fused to target proteins through genetic engineering, allowing researchers to identify, purify, or track the expressed proteins using specific monoclonal antibodies.
c-Myc 製品リスト
You Have Viewed 0 Of 0 Results
治験薬に関する情報
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| XNW-34017 | XNW-34017; XNW34017 | Phase 2 Clinical | Evopoint Biosciences Co Ltd | Neoplasm Metastasis; Solid tumours | 詳細 |
| Sepantronium Bromide | YM-155; YM155 monobromide; PC-002 | Phase 2 Clinical | Astellas Pharma Inc | Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Lymphatic Diseases; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Prostatic Neoplasms; Solid tumours | 詳細 |
| OMO-103 | OMO-103; OMO103 | Phase 2 Clinical | Peptomyc SL | Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Osteosarcoma; Pancreatic Neoplasms; Solid tumours | 詳細 |
| WP-1066 | WP-1066 | Phase 2 Clinical | Moleculin Biotech Inc | Brain metastases; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Medulloblastoma; Melanoma | 詳細 |
| PLX-51107 | PLX-51107 | Phase 1 Clinical | Plexxikon Inc | Graft vs Host Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Solid tumours | 詳細 |
| SACT-1 | SACT-1 | Phase 1 Clinical | Aptorum Group Llc | Neuroblastoma | 詳細 |
| Myrtleciclib | VS 2370; VS2-370 | Phase 1 Clinical | Vichem Chemie | HIV Infections; Neoplasms | 詳細 |
| WBC100 | WBC100; WBC-100 | Phase 1 Clinical | Hangzhou Weben Pharmaceutical Co Ltd | Hematologic Neoplasms; Leukemia, Myeloid, Acute; Neoplasms; Solid tumours | 詳細 |
| Luxeptinib | CG026806; CG-806; CG’806; CG-026806 | Phase 1 Clinical | Crystalgenomics Inc | Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes | 詳細 |
| Misetionamide | GP-2250 | Phase 1 Clinical | Geistlich Pharma | Pancreatic Neoplasms | 詳細 |